Immunogenic Mutant Peptide Screening Platform

Abstract

The present disclosure provides methods of identifying a disease- specific immunogenic peptide through a series of selection steps. Immunogenic epitopes identified by methods of the present disclosure are applicable for use in peptide-based immunotherapy, preferably cancer therapy. Furthermore, the methods of the present disclosure may be performed in a high-throughput manner and serve as a means of personalized vaccine development and therapy. Also provided are compositions of immunogenic peptides as well as methods of treatment comprising said compositions.


Claims

Download Citation


Sign in to the Lens

Feedback